Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FIROUZI ATA; Moussavi Ali Kazem; MOHEBBI AHMAD; ALEMZADEH ANSARI MOHAMMAD JAVAD; KIANI REZA; SANATI HAMID REZA; MOHEBBI BAHRAM; SHAKERIAN FARSHAD; ZAHEDMEHR ALI; Ansari Ramandi Mohammad Mostafa; Oni Heris Saeed; GHALESHI BAHAR; GHORBANI FATEMEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Cardiovascular and Thoracic Research Year:2018 | Volume:10 | Issue:3 Page(s): 149-152

Download Full-Text

View:

143

Download:

Cites:

Information Journal Paper

Title

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention

Author(s)

Keywords

Contrast-induced Nephropathy

Statin

Percutaneous coronary intervention

Abstract

Introduction: There is some controversy over the efficacy of Statins for the prevention of contrastinduced nephropathy (CIN). There have also been reports on varying efficacies of different Statins. Hence, in this study the efficacy of atorvaStatin and rosuvaStatin for the prevention of CIN was assessed. Methods: This single-blind randomized clinical trial was performed on 495 random patients with myocardial infarction with ST-segment elevation undergoing primary Percutaneous coronary intervention (PCI) in a training referral hospital in 2015. Patients were randomly assigned to receive either atorvaStatin 80 mg at admission and daily or rosuvaStatin 40 mg at admission and daily. CIN was defined based on serum creatinine elevation after 48 hours from the PCI. Results: The incidence of CIN was observed in 63 patients (21. 4%) After 48 hours from primary PCI. Of those, 17% (n = 50) were grade 1 CIN, while 4. 4% (n = 13) were grade 2 CIN. There was no significant difference between rosuvaStatin group compared with atorvaStatin group, regarding the CIN grading (P = 0. 14). Conclusion: Our results indicate that atorvaStatin and rosuvaStatin have similar efficacy for the prevention of CIN.

Cites

No record.

References

No record.

Cite

APA: Copy

FIROUZI, ATA, Moussavi, Ali Kazem, MOHEBBI, AHMAD, ALEMZADEH ANSARI, MOHAMMAD JAVAD, KIANI, REZA, SANATI, HAMID REZA, MOHEBBI, BAHRAM, SHAKERIAN, FARSHAD, ZAHEDMEHR, ALI, Ansari Ramandi, Mohammad Mostafa, Oni Heris, Saeed, GHALESHI, BAHAR, & GHORBANI, FATEMEH. (2018). Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 10(3), 149-152. SID. https://sid.ir/paper/314973/en

Vancouver: Copy

FIROUZI ATA, Moussavi Ali Kazem, MOHEBBI AHMAD, ALEMZADEH ANSARI MOHAMMAD JAVAD, KIANI REZA, SANATI HAMID REZA, MOHEBBI BAHRAM, SHAKERIAN FARSHAD, ZAHEDMEHR ALI, Ansari Ramandi Mohammad Mostafa, Oni Heris Saeed, GHALESHI BAHAR, GHORBANI FATEMEH. Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH[Internet]. 2018;10(3):149-152. Available from: https://sid.ir/paper/314973/en

IEEE: Copy

ATA FIROUZI, Ali Kazem Moussavi, AHMAD MOHEBBI, MOHAMMAD JAVAD ALEMZADEH ANSARI, REZA KIANI, HAMID REZA SANATI, BAHRAM MOHEBBI, FARSHAD SHAKERIAN, ALI ZAHEDMEHR, Mohammad Mostafa Ansari Ramandi, Saeed Oni Heris, BAHAR GHALESHI, and FATEMEH GHORBANI, “Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention,” JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, vol. 10, no. 3, pp. 149–152, 2018, [Online]. Available: https://sid.ir/paper/314973/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops